Cross Country Healthcare ... (CCRN)
NASDAQ: CCRN
· Real-Time Price · USD
13.37
0.04 (0.30%)
At close: Jun 13, 2025, 3:59 PM
13.38
0.07%
After-hours: Jun 13, 2025, 05:50 PM EDT
Cross Country Healthcare Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 |
|---|---|---|
| Other Services Revenue | 41.65M | 56.16M |
| Other Services Revenue Growth | -25.84% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 52.49M | 35.42M | 54.3M | 79.12M | 64.54M | 67.57M | 69.63M | 78.94M | 84.26M | 81.17M | 80.22M | 86.01M | 76.81M | 65.77M | 52.85M | 50.34M | 46.33M | 44.87M | 40.8M | 42.25M | 45.88M | 45.57M | 44.41M | 45.94M | 46.04M | 45.23M | 44.09M | 45.28M | 45.63M | 46.25M | 47.35M | 46.6M | 47.24M | 46.29M | 45.92M | 44.67M | 42.93M | 39.99M | 39.23M | 40.89M | 41.17M |
| Selling, General, and Administrative Revenue Growth | +48.17% | -34.76% | -31.37% | +22.58% | -4.48% | -2.96% | -11.80% | -6.32% | +3.81% | +1.19% | -6.74% | +11.97% | +16.78% | +24.46% | +4.97% | +8.67% | +3.25% | +9.96% | -3.43% | -7.91% | +0.68% | +2.62% | -3.35% | -0.20% | +1.79% | +2.59% | -2.65% | -0.77% | -1.34% | -2.31% | +1.60% | -1.35% | +2.04% | +0.80% | +2.79% | +4.06% | +7.36% | +1.95% | -4.07% | -0.67% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |